Cargando…

Analysis of gene expression and chemoresistance of CD133(+ )cancer stem cells in glioblastoma

BACKGROUND: Recently, a small population of cancer stem cells in adult and pediatric brain tumors has been identified. Some evidence has suggested that CD133 is a marker for a subset of leukemia and glioblastoma cancer stem cells. Especially, CD133 positive cells isolated from human glioblastoma may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Gentao, Yuan, Xiangpeng, Zeng, Zhaohui, Tunici, Patrizia, Ng, Hiushan, Abdulkadir, Iman R, Lu, Lizhi, Irvin, Dwain, Black, Keith L, Yu, John S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1697823/ https://www.ncbi.nlm.nih.gov/pubmed/17140455 http://dx.doi.org/10.1186/1476-4598-5-67

Ejemplares similares

Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma
por: Liu, Chao Lien, et al.
Publicado: (2020)

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme
por: Brown, Daniel V., et al.
Publicado: (2015)

Mesenchymal stem cell-like properties of CD133(+) glioblastoma initiating cells
por: Pavon, Lorena Favaro, et al.
Publicado: (2016)

CD133 Expression in Glioblastoma Multiforme: A Literature Review
por: Ahmed, Syed Ijlal, et al.
Publicado: (2018)

Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity
por: Brown, Daniel V., et al.
Publicado: (2017)

Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
por: Kase, Marju, et al.
Publicado: (2013)

Selective Lentiviral Gene Delivery to CD133-Expressing Human Glioblastoma Stem Cells
por: Bayin, N. Sumru, et al.
Publicado: (2014)

CD133 expression and MYCN amplification induce chemoresistance and reduce average survival time in pediatric neuroblastoma
por: Zhong, Zhi-Yong, et al.
Publicado: (2018)

Preferential Association of Lissencephaly-1 Gene Expression with CD133+ Glioblastoma Cells
por: Brehar, Felix Mircea, et al.
Publicado: (2017)

CD133 Regulates IL-1β Signaling and Neutrophil Recruitment in Glioblastoma
por: Lee, Seon Yong, et al.
Publicado: (2017)

An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma
por: Joyce, Thomas, et al.
Publicado: (2023)

Silencing of Btbd7 Inhibited Epithelial–Mesenchymal Transition and Chemoresistance in CD133(+) Lung Carcinoma A549 Cells
por: Fang, Li-Zhou, et al.
Publicado: (2017)

A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
por: Ahmed, Eroje M., et al.
Publicado: (2018)

Tropism of mesenchymal stem cell toward CD133(+) stem cell of glioblastoma in vitro and promote tumor proliferation in vivo
por: Pavon, Lorena Favaro, et al.
Publicado: (2018)

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
por: Liu, Qinghai, et al.
Publicado: (2009)

Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies
por: Jing, Hua, et al.
Publicado: (2016)

Pathological features of transplanted tumor established by CD133 positive TJ905 glioblastoma stem-like cells
por: Jin, Feng, et al.
Publicado: (2015)

Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
por: Zhu, Xuekai, et al.
Publicado: (2014)

Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma
por: Tunici, Patrizia, et al.
Publicado: (2004)

CD103 Deficiency Promotes Autism (ASD) and Attention-Deficit Hyperactivity Disorder (ADHD) Behavioral Spectra and Reduces Age-Related Cognitive Decline
por: Jhun, Michelle, et al.
Publicado: (2020)

Malignant behaviorial characteristics of CD133(+/−) glioblastoma cells from a Northern Chinese population
por: LIU, XIAOZHI, et al.
Publicado: (2013)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
por: Ni, Miaozhong, et al.
Publicado: (2015)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model
por: Hu, Jinwei, et al.
Publicado: (2007)

An emerging role of CD9 in stemness and chemoresistance
por: Ullah, Mujib, et al.
Publicado: (2019)

CD133: a stem cell biomarker and beyond
por: Li, Zhong
Publicado: (2013)

Prostate Cancer Stem Cells: The Role of CD133
por: Yang, Jianhui, et al.
Publicado: (2022)

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
por: Perazzoli, Gloria, et al.
Publicado: (2015)

Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients
por: Minajeva, Ave, et al.
Publicado: (2017)

CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity
por: Filppu, Pauliina, et al.
Publicado: (2021)

Novel approaches to combat chemoresistance against glioblastomas
por: Towner, Rheal A., et al.
Publicado: (2020)

Glioblastoma chemoresistance: roles of the mitochondrial melatonergic pathway
por: Anderson, George
Publicado: (2020)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

T Cells Enhance Stem-Like Properties and Conditional Malignancy in Gliomas
por: Irvin, Dwain K., et al.
Publicado: (2010)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

Investigating the Link between Molecular Subtypes of Glioblastoma, Epithelial-Mesenchymal Transition, and CD133 Cell Surface Protein
por: Zarkoob, Hadi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4o863q8hgn31vtf68t4o6tkde7